GERALD M. LIEBERMAN - 04 Aug 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Director
Signature
/s/ Dov Bergwerk as attorney-in-fact for Gerald M. Lieberman
Issuer symbol
TEVA
Transactions as of
04 Aug 2023
Net transactions value
$0
Form type
4
Filing time
07 Aug 2023, 16:05:41 UTC
Previous filing
20 Jun 2023
Next filing
23 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +15,810 +23% 84,917 04 Aug 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -15,810 -100% $0.000000* 0 04 Aug 2023 Ordinary Shares 15,810 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on August 4, 2022 and vested on August 4, 2023.